Nicotine, cotinine, withdrawal, and craving patterns during smoking and nicotine nasal spray use: Results from a pilot study with African American men

Nicotine and Tobacco Research

Volumn 9, Issue 1, 2007, Pages 65-82

  Mabry, Patricia L ^a   Tooze, Janet A ^b   Moser, Richard P ^a   Augustson, Erik M ^a   Malcolm, Robert J ^c   Benowitz, Neal L ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; NICOTINE; NOSE SPRAY; GANGLION STIMULATING AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD ANALYSIS; BURNING SENSATION; CIGARETTE SMOKING; CLINICAL ARTICLE; COUGHING; DRUG METABOLISM; FEASIBILITY STUDY; HOSPITAL PATIENT; HUMAN; MALE; NICOTINE REPLACEMENT THERAPY; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; SEX DIFFERENCE; SIDE EFFECT; SMOKING CESSATION; SNEEZING; STATISTICAL MODEL; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; ALGORITHM; BLOOD; DRUG ADMINISTRATION; ETHNOLOGY; IMPULSE CONTROL DISORDER; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; SMOKING; STATISTICS;

ADMINISTRATION, INTRANASAL; ADULT; AFRICAN AMERICANS; ALGORITHMS; COTININE; DRUG ADMINISTRATION SCHEDULE; GANGLIONIC STIMULANTS; HUMANS; IMPULSE CONTROL DISORDERS; MALE; NICOTINE; PILOT PROJECTS; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TOBACCO USE DISORDER;

EID: 34247855874     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1080/14622200601078327     Document Type: Article

References (52)

1. Akaike, H. (1974) A new look at the statistical model identification. IEEE Trans Automatic Control, 19, pp. 716-723.
2. Armitage, A. K. and Turner, D. M. (1970) Absorption of nicotine in cigarette and cigar smoke through the oral mucosa. Nature, 226, pp. 1231-1232.
3. Bansal, M. A., Cummings, K. M., Hyland, A. and Giovino, G. A. (2004) Stop-smoking medications: Who uses them, who misuses them, and who is misinformed about them?. Nicotine & Tobacco Research, 6, pp. S303-S310.
4. Benowitz, N. L. (1986) The human pharmacology of nicotine. Research Advances in Alcohol and Drug Problems, 9, pp. 1-51.
5. Benowitz, N. L. (1990) Pharmacokinetic considerations in understanding nicotine dependence. Ciba Foundation Symposium, 152, pp. 186-200.
6. Benowitz, N. L. and Hatsukami, D. K. (1998) Gender differences in the pharmacology of nicotine addiction. Addiction Biology, 3, pp. 383-404.
7. Benowitz, N. L., Herrera, B. and Jacob, P. 3rd. (2004) Mentholated cigarette smoking inhibits nicotine metabolism. Journal of Pharmacology and Experimental Therapeutics, 310, pp. 1208-1215.
8. Benowitz, N. L. and Jacob, P. 3rd. (1997) Individual differences in nicotine kinetics and metabolism in humans. NIDA Research Monographs, 173, pp. 48-64.
9. Benowitz, N. L., Kuyt, F. and Jacob, P. 3rd. (1982) Circadian blood nicotine concentrations during cigarette smoking. Clinical Pharmacology and Therapeutics, 32, pp. 758-764.
10. Benowitz, N. L., Perez-Stable, E. J., Herrera, B. and Jacob, P. 3rd. (2002) Slower metabolism and reduced intake of nicotine from cigarette smoking in Chinese-Americans. Journal of the National Cancer Institute, 94, pp. 108-115.
11. Benowitz, N. L., Zevin, S. and Jacob, P. 3rd. (1997) Sources of variability in nicotine and cotinine levels with use of nicotine nasal spray, transdermal nicotine, and cigarette smoking. British Journal of Clinical Pharmacology, 43, pp. 259-267.
12. Bridges, R. B., Humble, J. W., Turbek, J. A. and Rehm, S. R. (1986) Smoking history, cigarette yield and smoking behavior as determinants of smoke exposure. European Journal of Respiratory Disease, 146, pp. 129-137.
13. Caggiula, A. R., Donny, E. C., Chaudhri, N., Perkins, K. A., Evans-Martin, F. F. and Sved, A. F. (2002) Importance of nonpharmacological factors in nicotine self-administration. Physiology and Behavior, 77, pp. 683-687.
14. Choi, W. S., Okuyemi, K. S., Kaur, H. and Ahluwalia, J. S. (2004) Comparison of smoking relapse curves among African-American smokers. Addictive Behaviors, 29, pp. 1679-1683.
15. Cox, L. S., Tiffany, S. T. and Christen, A. G. (2001) Evaluation of the Brief Questionnaire of Smoking Urges (QSU-Brief) in laboratory and clinical settings. Nicotine & Tobacco Research, 3, pp. 7-16.
16. Cummings, K. M., Hyland, A., Giovino, G. A., Hastrup, J., Bauer, J. and Bansal, M. A. (2004) Are smokers adequately informed about the health risks of smoking and medicinal nicotine?. Nicotine & Tobacco Research, 6, pp. S333-S340.
17. Dempsey, D., Tutka, P., Jacob, P. 3rd., Allen, F., Schoedel, K., Tyndale, R. F. and Benowitz, N. L. (2004) Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clinical Pharmacology and Therapeutics, 76, pp. 64-72.
18. Diggle, P. J., Liang, K-Y. and Zeger, S. L. (1994) Analysis of longitudinal data, pp. 55-116. Oxford University Press, Oxford
19. Fiore, M. C., Bailey, W. C., Cohen, S. J., Dorfman, S. F., Gritz, E. R., Heyman, R. B., Holbrook, J., Jaen, C. R., Kottke, T. E., Lando, H. A., Mecklenbur, R., Mullen, P. D., Nett, L. M., Robinson, L., Stitzer, M., Tommasello, A. C., Villejo, L. and Wewers, M. E. (2000) Treating tobacco use and dependence. Clinical practice guideline, U.S. Department of Health and Human Services. Public Health Service, Rockville, MD
20. Gupta, S. K., Hwang, S. S., Causey, D., Rolf, C. N. and Gorsline, J. (1995) Comparison of the nicotine pharmacokinetics of Nicoderm (nicotine transdermal system) and half-hourly cigarette smoking. Journal of Clinical Pharmacology, 35, pp. 985-989.
21. Hajek, P., West, R., Foulds, J., Nilsson, F., Burrows, S. and Meadow, A. (1999) Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Archives of Internal Medicine, 159, pp. 2033-2038.
22. Harris, R. E., Zang, E. A., Anderson, J. I. and Wynder, E. L. (1993) Race and sex differences in lung cancer risk associated with cigarette smoking. International Journal of Epidemiology, 22, pp. 592-599.
23. Heatherton, T. F., Kozlowski, L. T., Frecker, R. C. and Fagerström, K. O. (1991) The Fagerström Test for Nicotine Dependence: A revision of the Fagerström Tolerance Questionnaire. British Journal of Addiction, 86, pp. 1119-1127.
24. Herning, R. I., Jones, R. T., Benowitz, N. L. and Mines, A. H. (1983) How a cigarette is smoked determines blood nicotine levels. Clinical Pharmacology and Therapeutics, 33, pp. 84-90.
25. Hjalmarson, A., Franzon, M., Westin, A. and Wiklund, O. (1994) Effect of nicotine nasal spray on smoking cessation. Archives of Internal Medicine, 154, pp. 2567-2672.
26. Hughes, J. and Hatsukami, D. K. (1998) Errors in using tobacco withdrawal scale. Tobacco Control, 7, pp. 92-93.
27. Hughes, J. R., Keely, J. and Naud, S. (2004) Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction, 99, pp. 29-38.
28. Hurt, R. D., Dale, L. C., Croghan, G. A., Croghan, I. T., Gomez-Dahl, L. C. and Offord, K. P. (1998) Nicotine nasal spray for smoking cessation: Patterns of use, side effects, relief of withdrawal symptoms and cotinine levels. Mayo Clinic Proceedings, 73, pp. 118-125.
29. Jacob, P. III., Wilson, M. and Benowitz, N. L. (1981) Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. Journal of Chromatography, 222, pp. 61-70.
30. 2 in humans. Biological Mass Spectrometry, 20, pp. 247-252.
31. Jones, R. L., Nguyen, A. and Man, S. F. P. (1998) Nicotine and cotinine replacement when nicotine nasal spray is used to quit smoking. Psychopharmacology, 137, pp. 345-350.
32. Lawson, G. M., Hurt, R. D., Dale, L. C., Offord, K. P., Croghan, I. T., Schroeder, D. R. and Jiang, N. S. (1998) Application of serum nicotine and plasma cotinine concentration to assessment of nicotine replacement in light, moderate, and heavy smokers undergoing transdermal therapy. Journal of Clinical Pharmacology, 38, pp. 502-509.
33. Lee, J. H., Ku, J., Kim, K., Kim, B., Kim, I. Y., Yang, B. H., Kim, S. H., Wiederhold, B. K., Wiederhold, M. D., Park, D. W., Lim, Y. and Kim, S. I. (2003) Experimental application of virtual reality for nicotine craving through cue exposure. Cyberpsychology and Behavior, 6, pp. 275-280.
34. Lerman, C., Kaufmann, V., Rukstalis, M., Patterson, F., Perkins, K., Audrain-McGovern, J. and Benowitz, N. (2004) Individualizing nicotine replacement therapy for the treatment of tobacco dependence: A randomized trial. Annals of Internal Medicine, 140, pp. 426-433.
35. Mooney, M., Babb, D., Jensen, J. and Hatsukami, D. (2005) Interventions to increase use of nicotine gum: A randomized, controlled, single-blind trial. Nicotine & Tobacco Research, 7, pp. 1-15.
36. Pankow, J. F., Tavakoli, A. D., Luo, W. and Isabelle, L. M. (2003) Percent free base nicotine in the tobacco smoke particulate matter of selected commercial and reference cigarettes. Chemical Research and Toxicology, 16, pp. 1014-1018.
37. Perez-Stable, E., Herrera, B., Jacob, P. and Benowitz, N. L. (1998) Nicotine metabolism and intake in Black and White smokers. The Journal of the American Medical Association, 280, pp. 152-156.
38. Perkins, K. A. (1996) Sex differences in nicotine vs non-nicotine reinforcement as determinants of tobacco smoking. Experimental and Clinical Psychopharmacology, 4, pp. 166-177.
39. Perkins, K. A., Grobe, J. E., Stiller, R. L., Fonte, C. and Goettler, J. E. (1992) Nasal spray nicotine replacement suppresses cigarette smoking desire and behavior. Clinical Pharmacology and Therapeutics, 52, pp. 627-634.
40. Polednak, A. P. (2004) Lung cancer incidence trends in Black and White young adults by gender (United States). Cancer Causes & Control, 15, pp. 665-670.
41. Russell, M. A. and Feyerabend, C. (1978) Cigarette smoking: A dependence on high-nicotine boli. Drug Metabolism Reviews, 8, pp. 29-57.
42. Sachs, D. P. and Benowitz, N. L. (1996) Individualizing medical treatment for tobacco dependence. European Respiratory Journal, 9, pp. 629-631.
43. Schievelbein, H., Eberhardt, R., Loschenkohl, K., Rahlfs, V. and Bedall, F. K. (1973) Absorption of nicotine through the oral mucosa. I. Measurement of nicotine concentration in the blood after application of nicotine and total particulate matter. Agents and Actions, 3, pp. 254-258.
44. Schneider, M. P., van Melle, G., Uldry, C., Huynh-Ba, M., Stubi, L. Fallab, Iorillo, D., Burnier, M. and Zellweger, J. P. (2003) Electronic monitoring of long-term use of the nicotine nasal spray and predictors of success in a smoking cessation program. Nicotine & Tobacco Research, 5, pp. 719-727.
45. Stone, A. A., Shiffman, S., Schwartz, J. E., Broderick, J. E. and Hufford, M. R. (2002) Patient non-compliance with paper diaries. British Medical Journal, 324, pp. 1193-1194.
46. Strasser, A. A., Kaufmann, V., Jepson, C., Perkins, K. A., Pickworth, W. B., Wileyto, E. P., Rukstalis, M., Audrain-McGovern, J. and Lerman, C. (2005) Effects of different nicotine replacement therapies on postcessation psychological responses. Addictive Behaviors, 30, pp. 9-17.
47. Sutherland, G., Stapleton, J. A., Russell, M. A., Jarvis, M. J., Hajek, P., Belcher, M. and Feyerabend, C. (1992) Randomised controlled trial of nasal nicotine spray in smoking cessation. Lancet, 340, pp. 342-349.
48. Tonnesen, P., Mikkelsen, Norregaard, J. and Jorgensen, S. (1996) Recycling of hard-core smokers with nicotine nasal spray. European Respiratory Journal, 9, pp. 1619-1623.
49. Tonnesen, P., Paoletti, P., Gustavsson, G., Russell, M. A., Saracci, R., Gulsvik, A., Rijcken, B. and Sawe, U. (1999) Higher dosage nicotine patches increase one-year smoking cessation rates: Results from the European CEASE trial. Collaborative European Anti-Smoking Evaluation. European Respiratory Journal, 13, pp. 238-246.
50. Tooze, J. A., Grunwald, G. K. and Jones, R. H. (2002) Analysis of repeated measures data with clumping at zero. Statistical Methods in Medical Research, 11, pp. 341-355.
51. US Department of Health and Human Services Tobacco use among U.S. racial/ ethnic groups-African Americans, American Indian and Alaska Natives, Asian Americans and Pacific Islanders, and Hispanics: A report of the surgeon general
52. Zacny, J. P., Stitzer, M. L., Brown, F. J., Yingling, J. E. and Griffiths, R. R. (1987) Human cigarette smoking: Effects of puff and inhalation parameters on smoke exposure. Journal of Pharmacology and Experimental Therapeutics, 240, pp. 554-564.